Overall AUC
0.83 area under ROC curve
- EndpointOverall ASPECTS-related classification performance
- Population137 non-contrast head CT scans from three U.S. institutions
- Tested versionBrainomix 360 e-ASPECTS configuration described in K243294
FDA-cleared profile
Brainomix Limited · CT/CTA · FDA-cleared (510(k))
Authorized purpose: Brainomix 360 e-ASPECTS registers adult non-contrast brain CT, segments ASPECTS regions, and provides an editable ASPECTS score with highlighted regions and voxel contribution views to assist trained clinicians evaluating suspected ischemic stroke within 24 hours of last known well.
Overview status: Source-reviewed overview
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
Clinical takeaway. Clinical role: Brainomix 360 e-ASPECTS registers adult non-contrast brain CT, segments ASPECTS regions, and provides an editable ASPECTS score with highlighted regions and voxel contribution views to assist trained clinicians evaluating suspected ischemic stroke within 24 hours of last known well.
Evidence takeaway. Evidence from the reviewed source record: K243294 FDA evidence is a regulatory ASPECTS segmentation and reader-assistance validation of Brainomix 360 e-ASPECTS; no independent paper or trial was promoted in this timeboxed review.
Evidence context not reviewed for this FDA record.
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Evidence
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Model sensitivity reported by ACR AI Central. Review endpoint, threshold, study population, and tested version before comparison.
Model specificity reported by ACR AI Central. Review endpoint, threshold, study population, and tested version before comparison.
0.83 area under ROC curve
0.69 proportion
0.97 proportion
0.85 area under ROC curve
K243294
Manufacturer-submitted FDA evidence; the reader comparison is regulatory evidence, not an independent clinical-outcome study.
Safety and lifecycle
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Price not public here; enter your quote
Not publicly available: Reviewed sources do not publish an exact-product procurement price with a stated offer scope.
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Source context, not route validation: Adult non-contrast brain CT DICOM images for suspected acute ischemic stroke within 24 hours of last known well; the FDA validation was tied to specified Siemens Somatom Definition scanner configurations.
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Field checked 2026-09-07 · FDA 510(k) K243294: Brainomix 360 e-ASPECTS
Source context, not route validation: The exact submission accepts brain CT DICOM through a standalone server or physical/virtual server, sends results to PACS or its web interface, and can provide compressed previews through configured channels; local DICOM routing, scanner compatibility, PACS behavior, and acknowledgement require acceptance testing.
Scope: Exact FDA submission.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Field checked 2026-09-07 · FDA 510(k) K243294: Brainomix 360 e-ASPECTS
Source context, not route validation: The FDA packet describes standalone off-the-shelf physical or virtual server deployment with DICOM transfer to PACS and a web interface; it does not establish current hosting region, retention, availability, service terms, or the installed infrastructure configuration.
Scope: Exact FDA submission.
Confirm processing location, queue ownership, exclusions and exact AI build.
Field checked 2026-09-07 · FDA 510(k) K243294: Brainomix 360 e-ASPECTS
Source context, not route validation: ASPECTS score from 0 to 10, highlighted ASPECTS regions, affected side and regions, voxel heatmap/contribution views, affected voxel volume, and editable clinician-reviewed results delivered through the configured workstation or PACS workflow.
Scope: Exact FDA submission.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Field checked 2026-09-07 · FDA 510(k) K243294: Brainomix 360 e-ASPECTS
Unresolved route: ASPECTS score from 0 to 10, highlighted ASPECTS regions, affected side and regions, voxel heatmap/contribution views, affected voxel volume, and editable clinician-reviewed results delivered through the configured workstation or PACS workflow.
Scope: Exact FDA submission.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Field checked 2026-09-07 · FDA 510(k) K243294: Brainomix 360 e-ASPECTS
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
No tests below have been performed or accepted.
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
Obtain current certificate scope, data-processing terms, hosting region, encryption, identity/access, audit, retention, and incident-response evidence for the deployed release.
Confirm exact release training, local competency, and escalation procedures.
Buyer acceptance guidance derived from the exact FDA workflow and validation scope; it is not a claimed vendor monitoring service.
Brainomix's current official FAQ describes Brainomix 360 support for major scanner and PACS manufacturers using DICOM, with engineers testing connections before go-live; confirm exact K243294 scanner scope and local interface behavior.
product family · checked 2026-09-07Current family FAQ; it does not establish every current feature or deployment term for the K243294 release.
The current family FAQ says clinicians can review and edit ASPECTS and that edits are labelled; local acceptance should verify edit provenance, PACS/web delivery, and the distinction between compressed previews and diagnostic source images.
product family · checked 2026-09-07Current family workflow context; exact K243294 implementation and configuration require confirmation.
The exact FDA submission describes physical or virtual server deployment with DICOM transfer and PACS/web result delivery; test scanner eligibility, series routing, processing latency, result acknowledgement, and downtime procedures.
exact submission · checked 2026-09-07Regulatory identity
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
Research record
This audit distinguishes completed source review from fields that have not yet been researched.
The stored PubMed and ClinicalTrials.gov candidate arrays were screened and were empty. No paper or trial was promoted; empty stored arrays do not establish that no external literature or trials exist. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, acr ai central product, vendor documentation, fda device recall, literature index, trial registry, stored candidate metadata, pubmed, clinical trials, openfda device recall
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
No public list price or contract unit for the exact K243294 configuration was established in the reviewed official sources.
Bounded web search on 2026-10-26 (query: "Brainomix 360 reimbursement CPT NTAP"; top results reviewed) found no vendor or payer page stating coding, coverage or payment for this product. No Brainomix page naming coding or payment for this product was found. This records what was found, not that none exists; eligibility depends on payer, site of service and use case.
8 sources - 3 history items
Scope: identity, clinicalUse, modality, anatomy, intendedUsers, careSetting, workflowRole, input, output, limitations, integration, deployment, training, evidenceMetrics, evidenceStudies
Scope: regulatoryIdentity, modalityContext
Scope: intendedUsers, careSetting, output, reportedSensitivity, reportedSpecificity, evidenceSummary, integration, anatomy, evidenceStudies, implementationCapabilities
Scope: evidenceDiscovery
Scope: evidenceDiscovery, studyStatus
Scope: recallDiscovery, nativeSubmissionMatching
Scope: productFamily, implementationCapabilities, security, training
Scope: postmarketSafety
Regulatory record
510(k)
Research record
human reviewed
Editorial review
Source-reviewed editorial overlay
Alternatives
iSchemaView
Authorized purpose: Rapid CTA 360 analyzes adult head CTA DICOM images to flag suspected large- and medium-vessel occlusion in specified intracranial and vertebral segments and notify trained clinicians for workflow triage; notifications are informational and not diagnostic.
NICo-Lab B.V.
Authorized purpose: Provide quantitative perfusion information in brain tissue for suspected ischemic stroke patients using dynamic brain CT perfusion studies; medical imaging professionals use the information as additional data in the standard-of-care assessment, not as a standalone diagnostic tool.
Brainomix Limited
Authorized purpose: Provides volumetric hyperdensity segmentation and quantification as an aid; physicians must review original images.
Methinks Software S.L.
Authorized purpose: Methinks CTA Stroke analyzes acute-setting brain CT angiography in adults over 21 with suspected stroke for suspected large-vessel occlusion in the terminal ICA, MCA-M1, or MCA-M2 and sends PACS and/or specialist notifications in parallel to standard care; previews are informational and not diagnostic.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Open existing correction destinationPermission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.
Correction policy and limits · Public repository change history